FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma – Curetoday.com
|
FDA Approves CAR–T Cell Therapy for Diffuse Large B-Cell Lymphoma
Curetoday.com The Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR–T cell therapy – for the treatment of adult patients who have relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have relapsed or are ineligible for an … |
